|
US5780222A
(en)
|
1995-04-10 |
1998-07-14 |
Alpha Therapeutic Corporation |
Method of PCR testing of pooled blood samples
|
|
EP0932390A1
(en)
*
|
1996-10-11 |
1999-08-04 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method
|
|
US20050025819A1
(en)
*
|
1997-07-14 |
2005-02-03 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US20020115609A1
(en)
*
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
|
US6372720B1
(en)
|
1998-02-05 |
2002-04-16 |
Kenneth J. Longmuir |
Liposome fusion and delivery vehicle
|
|
BR9911882A
(pt)
*
|
1998-07-13 |
2005-02-15 |
Univ Texas |
Processo de tratamento de câncer empregando anticorpos a aminofosfolipìdios
|
|
US6406693B1
(en)
|
1998-07-13 |
2002-06-18 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using antibodies to aminophospholipids
|
|
US6818213B1
(en)
|
1998-07-13 |
2004-11-16 |
Board Of Regents, The University Of Texas System |
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
|
|
CA2331789C
(en)
*
|
1998-07-13 |
2013-09-10 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
|
|
US6379698B1
(en)
*
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
AU783647B2
(en)
*
|
1999-04-20 |
2005-11-17 |
University Of British Columbia, The |
Cationic peg-lipids and methods of use
|
|
EP1880736A1
(en)
|
1999-04-23 |
2008-01-23 |
Alza Corporation |
Releasable linkage and composition containing same
|
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
AUPQ014699A0
(en)
*
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
WO2001041738A2
(en)
*
|
1999-12-10 |
2001-06-14 |
Celator Technologies Inc. |
Lipid carrier compositions with protected surface reactive functions
|
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
|
WO2002036073A2
(en)
*
|
2000-11-02 |
2002-05-10 |
Smithkline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
|
WO2002057424A2
(en)
*
|
2001-01-17 |
2002-07-25 |
Zycos Inc. |
Nucleic acid delivery formulations
|
|
JP2004525138A
(ja)
*
|
2001-03-26 |
2004-08-19 |
アルザ・コーポレーシヨン |
治療剤の改良された細胞内送達のためのリポソーム組成物
|
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
|
AU2002368202B2
(en)
|
2001-11-02 |
2008-06-05 |
Insert Therapeutics, Inc |
Methods and compositions for therapeutic use of RNA interference
|
|
US20040219201A1
(en)
*
|
2001-12-06 |
2004-11-04 |
Yechezkel Barenholz |
Tempamine compositions and methods of use
|
|
US20040147466A1
(en)
*
|
2002-01-17 |
2004-07-29 |
Barman Shikha P. |
Nucleic acid delivery formulations
|
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
US7211250B2
(en)
|
2002-07-18 |
2007-05-01 |
Helix Biopharma Corporation |
Method and composition for inhibiting cancer cell growth
|
|
FR2848101B1
(fr)
*
|
2002-12-04 |
2006-08-11 |
Oreal |
Procede de traitement cosmetique des matieres keratiniques impliquant la liberation controlee de principes actifs aromatiques a partir de particules de polymere aromatique
|
|
US20040161468A1
(en)
*
|
2002-12-04 |
2004-08-19 |
L'oreal |
Stabilization of aromatic active principles using aromatic polymers
|
|
JP2006517917A
(ja)
*
|
2002-12-19 |
2006-08-03 |
アルザ・コーポレーシヨン |
血管新生性の組織増殖の治療方法
|
|
JP4903036B2
(ja)
|
2003-01-06 |
2012-03-21 |
アンジオケム・インコーポレーテッド |
血液脳関門を通過する担体としてのアプロチニンおよび類似体
|
|
EP1610763A2
(en)
*
|
2003-03-31 |
2006-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Stable liposomes or micelles comprising a sphingolipid and a peg-lipopolymer
|
|
US20060115523A1
(en)
*
|
2004-12-01 |
2006-06-01 |
Konduri Kameswari S |
Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
|
|
US8846079B1
(en)
|
2004-12-01 |
2014-09-30 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
US11324698B2
(en)
|
2003-08-28 |
2022-05-10 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
|
EP1691780A2
(en)
*
|
2003-11-21 |
2006-08-23 |
Alza Corporation |
Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
|
|
US7208174B2
(en)
*
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
|
US20080050391A1
(en)
*
|
2004-03-30 |
2008-02-28 |
Lazarus Alan H |
Method for Treating Autoimmune Diseases With Antibodies
|
|
US20050265925A1
(en)
*
|
2004-04-21 |
2005-12-01 |
Samuel Zalipsky |
Releasable linkage and compositions containing same
|
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
|
US7468350B2
(en)
|
2004-06-16 |
2008-12-23 |
Pneumrx, Inc. |
Glue composition for lung volume reduction
|
|
CA2570261C
(en)
*
|
2004-07-08 |
2014-06-10 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
|
AU2005281352B2
(en)
*
|
2004-09-09 |
2011-01-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal compositions of glucocorticoid and glucocorticoid derivatives
|
|
US20080063702A1
(en)
*
|
2004-09-09 |
2008-03-13 |
Yechezkel Barenholz |
Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions
|
|
US6998028B1
(en)
*
|
2004-09-24 |
2006-02-14 |
Superpower, Inc. |
Methods for forming superconducting conductors
|
|
TW200612993A
(en)
*
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
CN101102752A
(zh)
*
|
2004-11-15 |
2008-01-09 |
耶路撒冷希伯来大学伊萨姆研发公司 |
联合优选为神经酰胺与细胞毒性药物的联合疗法
|
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
|
BRPI0520032A2
(pt)
*
|
2005-02-18 |
2009-04-14 |
Angiochem Inc |
moléculas para transportar um composto através da barreira hematoencefálica
|
|
WO2007005754A2
(en)
*
|
2005-07-01 |
2007-01-11 |
Alza Corporation |
Liposomal delivery vehicle for hydrophobic drugs
|
|
WO2007009229A1
(en)
|
2005-07-15 |
2007-01-25 |
Angiochem Inc. |
Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
|
|
US8998881B2
(en)
*
|
2005-08-10 |
2015-04-07 |
Alza Corporation |
Method for delivering drugs to tissue under microjet propulsion
|
|
EP1926780B1
(en)
|
2005-09-22 |
2013-08-14 |
Medivas, LLC |
Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
|
US8652504B2
(en)
|
2005-09-22 |
2014-02-18 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US20070212703A1
(en)
*
|
2005-09-27 |
2007-09-13 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
CN101365424A
(zh)
*
|
2005-12-08 |
2009-02-11 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
通过超声辐射改变脂质体组成的方法
|
|
US8067380B2
(en)
|
2005-12-19 |
2011-11-29 |
Industrial Technology Research Institute |
Glutathione-based delivery system
|
|
US7446096B2
(en)
*
|
2005-12-19 |
2008-11-04 |
Industrial Technology Research Institute |
Glutathione based delivery system
|
|
US20070190127A1
(en)
*
|
2005-12-30 |
2007-08-16 |
Mingdong Zhou |
Extended release of neuregulin for improved cardiac function
|
|
US8597636B2
(en)
*
|
2006-01-13 |
2013-12-03 |
Canadian Blood Services |
Method for treating autoimmune diseases and compositions therefor
|
|
US20070218116A1
(en)
*
|
2006-03-14 |
2007-09-20 |
Schwendener Reto A |
Compositions and methods for the treatment of tumors and tumor metastases
|
|
DE102007004303A1
(de)
*
|
2006-08-04 |
2008-02-07 |
Osram Opto Semiconductors Gmbh |
Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
|
|
US20090054317A1
(en)
*
|
2006-08-14 |
2009-02-26 |
Kane Ravindra S |
Polyvalent inhibitors of pathogens
|
|
EP2457589A1
(en)
*
|
2006-08-31 |
2012-05-30 |
Astellas Pharma Inc. |
Reverse targeting lipid vesicle
|
|
US20100297218A1
(en)
*
|
2006-09-20 |
2010-11-25 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
WO2009006311A2
(en)
*
|
2007-06-29 |
2009-01-08 |
Wisconsin Alumni Research Foundation |
Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
|
|
BRPI0815416A2
(pt)
*
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
CA2698812A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
|
EP2200932A4
(en)
*
|
2007-09-21 |
2014-09-10 |
Cytimmune Sciences Inc |
NANOTHERAPEUTIC COLLOIDAL METAL COMPOSITIONS AND METHODS
|
|
US10365224B2
(en)
|
2007-12-06 |
2019-07-30 |
Genalyte, Inc. |
Label-free optical sensors
|
|
WO2009127072A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Angiochem Inc. |
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
|
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
|
US8239357B1
(en)
*
|
2008-09-12 |
2012-08-07 |
Ryan, LLC |
Method and system for extracting information from electronic data sources
|
|
CA2740317A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
|
WO2010043047A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
WO2010062627A2
(en)
|
2008-10-27 |
2010-06-03 |
Genalyte Inc. |
Biosensors based on optical probing and sensing
|
|
US9914754B2
(en)
*
|
2008-12-05 |
2018-03-13 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
AU2009327267A1
(en)
|
2008-12-17 |
2011-07-14 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
|
WO2010082910A1
(en)
*
|
2009-01-15 |
2010-07-22 |
Board Of Regents Of The University Of Texas System |
Porous structures with modified biodegradation kinetics
|
|
WO2010091122A1
(en)
*
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
DE102009012640A1
(de)
*
|
2009-03-09 |
2010-09-30 |
Freie Universität Berlin |
Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung
|
|
ES2729261T3
(es)
|
2009-04-20 |
2019-10-31 |
Angiochem Inc |
Tratamiento del cáncer de ovario utilizando un agente anticancerígeno conjugado con un análogo de Angiopep-2
|
|
AU2010258892B2
(en)
|
2009-06-08 |
2015-08-13 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
EP2440250A1
(en)
|
2009-06-11 |
2012-04-18 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
|
WO2011000095A1
(en)
|
2009-07-02 |
2011-01-06 |
Angiochem Inc. |
Multimeric peptide conjugates and uses thereof
|
|
BR112012004094A2
(pt)
|
2009-08-24 |
2016-03-08 |
Amunix Operating Inc |
composições de fator vii de coagulação e métodos para fazer e usar as mesmas
|
|
EP2493918A4
(en)
|
2009-10-30 |
2013-04-10 |
Ntf Therapeutics Inc |
IMPROVED NEURTURINE MOLECULES
|
|
TWI397428B
(zh)
|
2009-12-29 |
2013-06-01 |
Ind Tech Res Inst |
標的第四介白素受體之傳輸系統
|
|
EP2531175A2
(en)
|
2010-02-01 |
2012-12-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
|
EP3266881B1
(en)
|
2010-11-05 |
2019-12-25 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
|
CA2839526A1
(en)
|
2011-06-23 |
2012-12-27 |
Dsm Ip Assets B.V. |
Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
|
|
HRP20201465T1
(hr)
|
2011-07-13 |
2021-02-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomi koji ko-inkapsuliraju bisfosfonat i amfipatsko sredstvo
|
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
|
HRP20221531T1
(hr)
|
2012-02-15 |
2023-02-17 |
Bioverativ Therapeutics Inc. |
Pripravci faktora viii i postupci dobivanja i korištenja istih
|
|
LT2822577T
(lt)
|
2012-02-15 |
2019-03-25 |
Bioverativ Therapeutics Inc. |
Rekombinantiniai faktoriaus viii baltymai
|
|
WO2013138251A1
(en)
|
2012-03-12 |
2013-09-19 |
The Board Of Trustes Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
|
WO2013184938A2
(en)
|
2012-06-08 |
2013-12-12 |
Alkermes. Inc. |
Fusion polypeptides comprising mucin-domain polypeptide linkers
|
|
CN102920658B
(zh)
*
|
2012-11-02 |
2015-01-21 |
艾韦特(溧阳)医药科技有限公司 |
与glp-1类似物和聚乙二醇结合的脂质体及其制备方法
|
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
|
JP6702866B2
(ja)
|
2013-11-18 |
2020-06-03 |
ルビウス セラピューティクス， インコーポレイテッド |
合成膜−レシーバー複合体
|
|
EP3122380B1
(en)
|
2014-03-25 |
2025-03-19 |
The Government of the United States of America as represented by the Secretary of the Army |
Non-toxic adjuvant formulation comprising a monophosphoryl lipid a (mpla)-containing liposome composition and a saponin
|
|
US20170173005A1
(en)
|
2014-03-27 |
2017-06-22 |
Research Foundation Of The City University Of New York |
Method for detecting or treating triple negative breast cancer
|
|
WO2015153102A1
(en)
|
2014-04-01 |
2015-10-08 |
Rubius Therapeutics, Inc. |
Methods and compositions for immunomodulation
|
|
EP3233067B1
(en)
|
2014-12-18 |
2019-11-06 |
DSM IP Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
|
WO2016116907A1
(en)
|
2015-01-23 |
2016-07-28 |
Helix Biopharma Corporation |
Antibody-urease conjugates for therapeutic purposes
|
|
JP6859275B2
(ja)
|
2015-03-17 |
2021-04-14 |
リポメディックス・ファーマシューティカルズ・リミテッドＬｉｐｏｍｅｄｉｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． |
膀胱がんの治療方法
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
MX2018001497A
(es)
|
2015-08-03 |
2018-05-15 |
Bioverativ Therapeutics Inc |
Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
|
|
WO2017048860A1
(en)
|
2015-09-14 |
2017-03-23 |
Vgsk Technologies, Inc. |
A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal
|
|
WO2017079582A1
(en)
|
2015-11-06 |
2017-05-11 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
|
WO2018102743A1
(en)
|
2016-12-02 |
2018-06-07 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilic arthropathy using chimeric clotting factors
|
|
CA3056797A1
(en)
|
2017-03-16 |
2018-09-20 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
|
CA3075822A1
(en)
|
2017-10-16 |
2019-04-25 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
|
RS66972B1
(sr)
|
2018-05-18 |
2025-07-31 |
Bioverativ Therapeutics Inc |
Metode lečenja hemofilije a
|
|
JP2020026397A
(ja)
*
|
2018-08-09 |
2020-02-20 |
国立大学法人 岡山大学 |
ＴｒｋＢアンタゴニストを含む医薬組成物
|
|
CA3182372A1
(en)
|
2020-06-25 |
2021-12-30 |
Amunix Pharmaceuticals, Inc. |
Her-2 targeted bispecific compositions and methods for making and using the same
|
|
AU2022241762A1
(en)
|
2021-03-24 |
2023-09-14 |
Mural Oncology, Inc. |
Upar antibodies and fusion proteins with the same
|
|
CA3217928A1
(en)
|
2021-05-05 |
2022-11-10 |
Kameswari S. Konduri |
Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation
|
|
US20250177516A1
(en)
|
2022-03-14 |
2025-06-05 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
IL321069A
(en)
|
2022-12-01 |
2025-07-01 |
Pfizer |
Pneumococcal conjugate vaccine preparations
|
|
WO2025057058A1
(en)
|
2023-09-13 |
2025-03-20 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
WO2025191415A1
(en)
|
2024-03-11 |
2025-09-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
|